Pristiq® (desvenlafaxine succinate) – First-time generic
March 1, 2017 – Teva launched AB-rated generic versions of Pfizer’s Pristiq (desvenlafaxine succinate) 25 mg, 50 mg, and 100 mg extended-release tablets for the treatment of major depressive disorder.
Download PDF